Cardiovascular Diseases
At Helsinki University Central Hospital the Heart and Lung Center concentrates on coronary artery disease, seeking to advance interventional care for patients with elevated bleeding risk.
- Evaluation of drug‑coated balloon therapy
- Comparison with drug‑eluting stents
- Shortened dual‑antiplatelet therapy regimens
- Strategies for high bleeding risk populations
Ongoing studies aim to demonstrate that a drug‑coated balloon approach combined with reduced dual‑antiplatelet therapy can be as effective as traditional drug‑eluting stents, offering safer options for those prone to bleeding.
